Massive transfusion and blood product use in the pediatric trauma patient

Seminars in Pediatric Surgery

Volumn 19, Issue 4, 2010, Pages 286-291

  Dehmer, Jeffrey J ^a   Adamson, William T ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Hemorrhage; Pediatric; Transfusion; Trauma

Indexed keywords

ALBUMIN; DEXTRAN; FRESH FROZEN PLASMA; HEMOGLOBIN; HETASTARCH; PLASMA SUBSTITUTE; POLYMERIZED HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SODIUM CHLORIDE; THROMBIN;

ABDOMINAL BLEEDING; ABDOMINAL COMPARTMENT SYNDROME; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CHILDHOOD INJURY; COLLOID; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE TRANSFUSION; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGIC SHOCK; HUMAN; LUNG HEMORRHAGE; LUNG INSUFFICIENCY; MULTIPLE ORGAN FAILURE; PNEUMONIA; PRIORITY JOURNAL; RESUSCITATION; SEPSIS; SEPTIC SHOCK; THROMBOCYTE TRANSFUSION;

BLOOD COMPONENT TRANSFUSION; BLOOD SUBSTITUTES; BLOOD VOLUME; CHILD; CLINICAL PROTOCOLS; FACTOR VIIA; HEMOGLOBINS; HUMANS; RECOMBINANT PROTEINS; SHOCK, HEMORRHAGIC; WOUNDS AND INJURIES;

EID: 77957287722     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2010.07.002     Document Type: Article

References (65)

1. Spinella P.C., Perkins J.G., Grathwohl K.W., et al. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009, 66:S69-S76.
2. Barcelona S.L., Thompson A.A., Cote C.J. Intraoperative pediatric blood transfusion therapy: a review of common issues. part II: Transfusion therapy, special considerations, and reduction of allogenic blood transfusions. Paediatr Anaesth 2005, 15:814-830.
3. Hardy J.F., de Moerloose P., Samama C.M. The coagulopathy of massive transfusion. Vox Sang 2005, 89:123-127.
4. Rossaint R., Bouillon B., Cerny V., et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010, 14:R52.
5. Lacroix J., Hebert P.C., Hutchison J.S., et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007, 356:1609-1619.
6. Stricker P.A., Shaw T.L., Desouza D.G., et al. Blood loss, replacement, and associated morbidity in infants undergoing craniofacial surgery. Paediatr Anaesth 2010, 20:150-159.
7. Jung J., Eo E., Ahn K., et al. Initial base deficit as predictors for mortality and transfusion requirement in the severe pediatric trauma except brain injury. Pediatr Emerg Care 2009, 25:579-581.
8. Schuster K.M., Davis K.A., Lui F.Y. The status of massive transfusion protocols in United States trauma centers: massive transfusion or massive confusion?. Transfusion 2010, 50:1545-1551.
9. Istaphanous GK, Wheeler DS, Lisco SJ, et al. Red blood cell transfusion in critically ill children: a narrative review. Pediatr Crit Care Med, in press.
10. Spinella PC, Dressler A, Tucci M, et al. Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009. Transfusion, in press.
11. Harken A.H. The surgical significance of the oxyhaemoglobin dissociation curve. Surg Gynecol Obstet 1977, 144:935-955.
12. Bosman G.J., Were J.M., Willekens F.L., et al. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008, 18:335-347.
13. Reiter C.D., Wang X., Tanus-Santos J.E., et al. Cell-free hemoglobin limits nitric oxide bio-availability in sickle-cell disease. Nat Med 2002, 8:1383-1389.
14. Kneyber M.C.J., Hersi M.I., Twisk J.W.R. Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med 2007, 33:1414-1422.
15. Sauaia A., Moore F.A., Moore E.E., et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995, 38:185-193.
16. Spinella P.C., Holcomb J.B. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009, 23:213-240.
17. Rotondo M.F., Schwab C.W., McGonigal M.D., et al. "Damage control": An approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993, 35:375-382.
18. Beekley A.C. Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. Crit Care Med 2008, 36:S267-S274.
19. Holcomb J.B., Jenkins D., Rhee P., et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007, 62:307-310.
20. Nunez T.C., Young P.P., Holcomb J.B. Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 2010, 68:1498-1505.
21. MacLeod J.B., Lynn M., McKenney M.G., et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003, 55:39-44.
22. Brohi K., Singh J., Heron M., et al. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130.
23. Niles S.E., McLaughlin D.F., Perkins J.G., et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma 2008, 64:1459-1463.
24. Manno C.S., Hedberg K.W., Kim H.C., et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991, 77:930-936.
25. Mou S.S., Giroir B.P., Molitor-Kirsch E.A., et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med 2004, 351:1635-1644.
26. Stinger H.K., Spinella P.C., Perkins J.G., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008, 64:S79-S85.
27. Sperry J.L., Ochoa J.B., Gunn S.R., et al. An FFP: PRBC transfusion ratio >/= 1. 1.5 Is associated with a lower risk of mortality after massive transfusion. J Trauma 2008, 65:986-993.
28. Gonzalez E.A., Moore F.A., Holcomb J.B., et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007, 62:112-119.
29. Inaba K., Branco B.C., Rhee P., et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010, 210:957-965.
30. Sarani B., Dunkman W.J., Dean L., et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008, 36:1114-1118.
31. Cinat M.E., Wallace W.C., Nastanski F., et al. Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg 1999, 134:964-968.
32. Ho A.M., Karmakar M.K., Dion P.W. Are we giving enough coagulation factors during major trauma resuscitation?. Am J Surg 2005, 190:479-484.
33. Hirshberg A., Dugas M., Banez E.I., et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 2003, 54:454-463.
34. Teixeira P.G., Inaba K., Shulman I., et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009, 66:693-697.
35. Bochicchio G.V., Napolitano L., Joshi M., et al. Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study. World J Surg 2008, 32:2185-2189.
36. Vamvakas E.C. Platelet transfusion and postoperative infection in cardiac surgery. Transfusion 2007, 47:352-354.
37. Cotton B.A., Au B.K., Nunez T.C., et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009, 66:41-48.
38. Velasco I.T., Pontieri V., Rocha e Silva M., et al. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol 1980, 239:H664-H673.
39. Rocha e Silva M., Velasco I.T., Nogueira da Silva R.I., et al. Hyperosmotic sodium salts reverse severe hemorrhagic shock: other solutes do not. Am J Physiol 1987, 253:H751-H762.
40. Younes R.N., Aun F., Accioly C.Q., et al. Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery 1992, 111:380-385.
41. Paul M., Dueck M., Herrmann H.J., et al. A randomized, controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch. 6 % (HES 70/0.5) vs. Lactated Ringer's solution. Paediatr Anaesth 2003, 13:603-608.
42. Sumpelmann R., Kretz F.J., Gabler R., et al. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European prospective multicenter observational postauthorization safety study (PASS). Paediatr Anaesth 2008, 18:929-933.
43. Hanart C., Khalife M., De Ville A., et al. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch; 130/0.4. Crit Care Med 2009, 37:696-701.
44. Rocha-e-Silva R., Caneo L.F., Filho D.D.L., et al. First use of hypertonic saline dextran in children: A study in safety and effectiveness for atrial septal defect surgery. Shock 2003, 20:427-430.
45. Bailey A.G., McNaull P.P., Jooste E., et al. Perioperative crystalloid and colloid fluid management in children: where are we and how did we get here?. Anesth Analg 2010, 110:375-390.
46. Jorgensen K.A., Stoffersen E. On the inhibitory effect of albumin on platelet aggregation. Thromb Res 1980, 17:13-18.
47. Jorgensen K.A., Stoffersen E. Heparin like activity of albumin. Thromb Res 1979, 16:569-574.
48. Tobias M.D., Wambold D., Pilla M.A., Greer F. Differential effects of serial hemodilution with hydroxyethyl starch, albumin, and 0.9% saline on whole blood coagulation. J Clin Anesth 1998, 10:366-371.
49. Gould S.A., Moore E.E., Hoyt D.B., et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 2002, 195:445-452.
50. Moore E.E., Moore F.A., Fabian T.C., et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg 2009, 208:1-13.
51. Handrigan M.T., Bentley T.B., Oliver J.D., et al. Choice of fluid influences outcome in prolonged hypotensive resuscitation in awake rats. Shock 2005, 23:337-343.
52. Kenet G., Walden R., Eldad A., Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999, 354:1879.
53. Yilmaz B.T., Alioglu B., Ozyurek E., et al. Successful use of recombinant factor VIIa (NovoSeven®) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia. Pediatr Cardiol 2005, 26:843-845.
54. Avci Z., Malbora B., Gokdemir M., et al. Successful use of recombinant factor VIIa (NovoSeven®) during cardiac surgery in a pediatric patient with congenital factor XI deficiency. Pediatr Cardiol 2008, 29:220-222.
55. Egan J.R., Lammi A., Schell D.N., Gillis J., Nunn G.R. Recombinant activated factor VII in paediatric cardiac surgery. Intensive Care Med 2004, 30:682-685.
56. Razon Y., Erez E., Vidne B., et al. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Paediatr Anaesth 2005, 15:235-240.
57. Brady K.M., Easley R.B., Tobias J.D. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Paediatr Anaesth 2006, 16:1042-1046.
58. Yilmaz D., Karapinar B., Balkan C., et al. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Pediatr Hematol Oncol 2008, 25:301-311.
59. Uhrig L., Blanot S., Baugnon T., et al. Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures. Pediatr Crit Care Med 2007, 8:576-579.
60. Morenski J.D., Tobias J.D., Jimenez D.F. Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. J Neurosurg 2003, 98:611-616.
61. Veldman A., Hoffman M., Ehrenforth S. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr Med Chem 2003, 10:797-811.
62. Zuppa A.F., Nadkarni V.M. Recent developments in the pharmacologic approach to pediatric critical care. Curr Opin Anaesthesiol 2004, 17:223-228.
63. Paterson N. Validation of a theoretically derived model for the management of massive blood loss in pediatric patients-a case report. Paediatr Anaesth 2009, 19:535-540.
64. Como J.J., Dutton R.P., Scalea T.M., et al. Blood transfusion rates in the care of acute trauma. Transfusion 2004, 44:809-813.
65. Malone D.L., Dunne J., Tracy J.K., et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003, 54:898-905.